JP2019526628A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019526628A5 JP2019526628A5 JP2019531594A JP2019531594A JP2019526628A5 JP 2019526628 A5 JP2019526628 A5 JP 2019526628A5 JP 2019531594 A JP2019531594 A JP 2019531594A JP 2019531594 A JP2019531594 A JP 2019531594A JP 2019526628 A5 JP2019526628 A5 JP 2019526628A5
- Authority
- JP
- Japan
- Prior art keywords
- msoh
- compound
- suitable solvent
- crystal form
- isolating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 40
- 239000002904 solvent Substances 0.000 claims 17
- 239000013078 crystal Substances 0.000 claims 16
- 239000000725 suspension Substances 0.000 claims 9
- 238000001035 drying Methods 0.000 claims 7
- 238000004519 manufacturing process Methods 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims 4
- 206010016654 Fibrosis Diseases 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 230000004761 fibrosis Effects 0.000 claims 3
- 230000003176 fibrotic effect Effects 0.000 claims 3
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 3
- 238000000634 powder X-ray diffraction Methods 0.000 claims 3
- 208000019425 cirrhosis of liver Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000001704 evaporation Methods 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000012296 anti-solvent Substances 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 238000003801 milling Methods 0.000 claims 1
- 201000002793 renal fibrosis Diseases 0.000 claims 1
- 239000002002 slurry Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022113230A JP2022137223A (ja) | 2016-08-31 | 2022-07-14 | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662382153P | 2016-08-31 | 2016-08-31 | |
| US62/382,153 | 2016-08-31 | ||
| PCT/US2017/049400 WO2018045043A1 (en) | 2016-08-31 | 2017-08-30 | Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022113230A Division JP2022137223A (ja) | 2016-08-31 | 2022-07-14 | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019526628A JP2019526628A (ja) | 2019-09-19 |
| JP2019526628A5 true JP2019526628A5 (enExample) | 2020-10-08 |
Family
ID=61241572
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531594A Pending JP2019526628A (ja) | 2016-08-31 | 2017-08-30 | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
| JP2022113230A Pending JP2022137223A (ja) | 2016-08-31 | 2022-07-14 | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022113230A Pending JP2022137223A (ja) | 2016-08-31 | 2022-07-14 | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10301287B2 (enExample) |
| EP (1) | EP3506896A4 (enExample) |
| JP (2) | JP2019526628A (enExample) |
| KR (1) | KR20190057066A (enExample) |
| CN (1) | CN110167550A (enExample) |
| AU (1) | AU2017321594A1 (enExample) |
| BR (1) | BR112019003987A2 (enExample) |
| CA (1) | CA3034606A1 (enExample) |
| MX (1) | MX2019002057A (enExample) |
| RU (1) | RU2019109019A (enExample) |
| SG (1) | SG11201901438VA (enExample) |
| TW (1) | TW201823235A (enExample) |
| WO (1) | WO2018045043A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019238041A1 (zh) * | 2018-06-12 | 2019-12-19 | 南京明德新药研发有限公司 | 一种丙烯酰胺类化合物的晶型及其制备方法 |
| WO2019245518A1 (en) * | 2018-06-18 | 2019-12-26 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| WO2019245517A1 (en) * | 2018-06-18 | 2019-12-26 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| US11426931B2 (en) | 2018-06-19 | 2022-08-30 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| WO2019245535A1 (en) | 2018-06-19 | 2019-12-26 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| US11298876B2 (en) | 2018-06-19 | 2022-04-12 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| EP3844209B1 (en) * | 2018-08-31 | 2022-06-22 | Evonik Operations GmbH | Process for preparing a polymer powder |
| WO2021133811A1 (en) | 2019-12-26 | 2021-07-01 | Teva Pharmaceuticals International Gmbh | Solid state forms of cenicriviroc and process for preparation thereof |
| WO2021233349A1 (zh) | 2020-05-22 | 2021-11-25 | 南京明德新药研发有限公司 | 吡啶类衍生物及其应用 |
| WO2022177014A1 (ja) * | 2021-02-22 | 2022-08-25 | 旭化成株式会社 | セルロースナノファイバーを含む組成物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62265270A (ja) | 1986-05-13 | 1987-11-18 | Zeria Shinyaku Kogyo Kk | 新規イミダゾ−ル誘導体およびそれらを有効成分とする抗潰瘍剤 |
| DE69520360T2 (de) | 1994-07-04 | 2001-08-09 | Takeda Chemical Industries, Ltd. | Phosphonsäure verbindungen imre herstellung und verwendung |
| CN1282243A (zh) | 1997-12-19 | 2001-01-31 | 武田药品工业株式会社 | 用于拮抗ccr5的含n－酰苯胺衍生物的药物组合物 |
| AU5301599A (en) | 1998-08-20 | 2000-03-14 | Takeda Chemical Industries Ltd. | Quaternary ammonium salts and their use |
| WO2001017947A1 (en) | 1999-09-06 | 2001-03-15 | Takeda Chemical Industries, Ltd. | Process for the preparation of 2,3-dihydroazepine compounds |
| DE60235632D1 (de) | 2001-08-08 | 2010-04-22 | Tobira Therapeutics Inc | Bicyclische verbindung, deren herstellung und verwendung |
| EP1484322A4 (en) | 2002-03-12 | 2008-01-23 | Takeda Pharmaceutical | PROCESS FOR PRODUCING AN OPTICALLY ACTIVE SULFOXIDE DERIVATIVE |
| US20080249147A1 (en) | 2004-03-24 | 2008-10-09 | Takeda Pharmaceutical Company Limited | Emulsion-Stabilized Preparation |
| JP2007269628A (ja) * | 2004-05-28 | 2007-10-18 | Takeda Chem Ind Ltd | 医薬化合物の結晶 |
| GT200600148A (es) | 2005-04-14 | 2006-11-22 | Metodos para el tratamiento y la prevencion de fibrosis | |
| PE20140406A1 (es) | 2010-11-18 | 2014-04-16 | Univ Yale | Moleculas bifuncionales con actividad de reclutamiento de anticuerpos y actividad inhibitoria inicial contra el virus de la inmunodeficiencia humana |
| EP2846788A1 (en) * | 2012-05-11 | 2015-03-18 | Akron Molecules AG | Use of compounds for the treatment of pain |
| UA115807C2 (uk) | 2013-05-15 | 2017-12-26 | Тобіра Терап'Ютикс, Інк. | Композиція (варіанти) ценікривіроку і спосіб її одержання та застосування (варіанти) |
| RU2020119611A (ru) | 2014-03-21 | 2020-06-29 | Тобира Терапьютикс, Инк. | Сенекривирок для лечения фиброза |
| US20170105969A1 (en) | 2014-06-02 | 2017-04-20 | Tobira Therapeutics, Inc. | Cenicriviroc for the treatment of hiv-2 infection |
| CN112266392A (zh) * | 2014-12-23 | 2021-01-26 | 妥必徕疗治公司 | 制备cenicriviroc及相关类似物的方法 |
-
2017
- 2017-08-30 RU RU2019109019A patent/RU2019109019A/ru not_active Application Discontinuation
- 2017-08-30 JP JP2019531594A patent/JP2019526628A/ja active Pending
- 2017-08-30 CA CA3034606A patent/CA3034606A1/en not_active Abandoned
- 2017-08-30 AU AU2017321594A patent/AU2017321594A1/en not_active Abandoned
- 2017-08-30 WO PCT/US2017/049400 patent/WO2018045043A1/en not_active Ceased
- 2017-08-30 MX MX2019002057A patent/MX2019002057A/es unknown
- 2017-08-30 EP EP17847477.1A patent/EP3506896A4/en not_active Withdrawn
- 2017-08-30 CN CN201780061529.6A patent/CN110167550A/zh active Pending
- 2017-08-30 KR KR1020197008786A patent/KR20190057066A/ko not_active Withdrawn
- 2017-08-30 TW TW106129555A patent/TW201823235A/zh unknown
- 2017-08-30 SG SG11201901438VA patent/SG11201901438VA/en unknown
- 2017-08-30 BR BR112019003987A patent/BR112019003987A2/pt not_active Application Discontinuation
- 2017-08-30 US US15/691,191 patent/US10301287B2/en active Active
-
2022
- 2022-07-14 JP JP2022113230A patent/JP2022137223A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019526628A5 (enExample) | ||
| JP6025755B2 (ja) | 多粒子ｌ−メントール製剤及びその関連する方法 | |
| JP2019509268A5 (enExample) | ||
| RU2019109019A (ru) | Твердые формы ценикривирок мезилата и способы изготовления твердых форм ценикривирок мезилата | |
| JP2018513863A5 (enExample) | ||
| JP2019516749A5 (enExample) | ||
| JP2010515682A5 (enExample) | ||
| JP2016539136A5 (enExample) | ||
| JP2011500780A5 (enExample) | ||
| AU2008247169A1 (en) | Polymorphic forms of bosentan | |
| JP2017515821A5 (enExample) | ||
| WO2016107289A1 (zh) | 制备索非布韦晶型6的方法 | |
| CN114746412A (zh) | Kd-025的新晶型及其制备方法 | |
| WO2010129636A2 (en) | Lenalidomide polymorph | |
| JP2018516946A5 (enExample) | ||
| JP2007519747A5 (enExample) | ||
| CN107427495A (zh) | 包含雷迪帕韦和索非布韦的药物组合物 | |
| TWI780270B (zh) | 固體分散體 | |
| US20190300483A1 (en) | POLYMORPHS OF BETRlXABAN & ITS MALEATE SALT | |
| CN1303065C (zh) | 氨溴索半胱氨酸类似物盐及其制备方法和用途 | |
| JP6621761B2 (ja) | 薬学的に活性な化合物の固体形態 | |
| JPWO2020051538A5 (enExample) | ||
| JP2020500907A5 (enExample) | ||
| RU2009104346A (ru) | Ксинафоатная соль замещенного 5-оксазол-2-ил-хинолинового соединения | |
| CN105198865A (zh) | 葛根素二水合物 |